Payment planning should begin with an accurate description of the business, not a list of supposedly peptide-friendly processors. Eligibility depends on the products, intended customers, jurisdictions and claims a merchant makes. A provider’s acceptance policy can change, so a forecast for 2027 should be treated as planning rather than a fact about future availability.

Stripe’s current FAQ distinguishes pharmaceutical businesses from certain non-prescription and research-peptide businesses, with conditions on claims and access. Its broader policy says approval can depend on additional diligence and can be modified or revoked. Neither page guarantees acceptance for a particular merchant. Stripe prohibited and restricted businesses FAQ Stripe prohibited and restricted businesses policy

Define the operating risk

Payment continuity involves more than successful checkout. A business needs to understand settlement timing, reserves, disputes, refunds and what happens if its product range changes. A processor that accepts the present catalog may not accept a later product or a different marketing approach.

A practical planning file records the exact business description submitted, the approved scope and any restrictions in writing. It also identifies who will review future changes before they reach checkout. This is more reliable than interpreting an account’s initial activation as permanent approval.

Prepare for interruptions honestly

A continuity plan should explain how outstanding orders and customer refunds will be handled if processing pauses. It should not rely on hiding product descriptions, routing prohibited sales through another category or opening accounts under misleading identities. Those tactics create additional operational and compliance risk.

AXON’s planning recommendation is to evaluate continuity, documentation and transparency together. Ask providers for current written terms and keep a dated record of the assessment. An attractive fee quote is useful only after the business model is eligible and the settlement conditions are understood.

This is an operational framework, not a processor recommendation or assurance of legal compliance.